20240626_OMRE_Penyampaian Bukti Iklan_31675459_lamp2.pdf

    President Commissioner            :   Mr. Dr. Ferry Siswojo Djongianto, SH, LLM
    Independent Vice
    President Commissioner            :   Mr. Drs. H. Lutfi Dahlan
    Commissioner                      :   Mr. Sriyanto
    Independent Commissioner          :   Mr. Drs. Ris Sutarto
    Independent Commissioner          :   Mr. Gatot Subroto
    Independent Commissioner          :   Mr. Drs. Syamsuddin Lologau

C. The Meeting was attended and represented by 2.879.881.322 shares with valid voting
   rights or 97,78 % of the Company’s total issued shares.

D. The Meeting had provided an opportunity for the shareholders to raise questions and/or
   provide opinion related to the agenda of the Meeting, but in the Meeting there were no
   shareholders or their proxies who asked questions and or gave opinions regarding the
   agenda Meeting.

E. Decision Making Mechanism of the Meeting :
   Resolutions of the Meeting were conducted openly and carried out by way of amicable
   discussion. In the event that the amicable agreement was not reached, decision
   making was adopted by way of voting.

F. Voting results for every agenda item of the Meeting:

        Agenda                 Approve              Not Approve            Abstain
          1                 2.879.881.322                0                   0
                                100%
            2               2.879.881.322                 0                   0
                                100%
            3               2.879.881.322                 0                   0
                                100%



G. Resolutions of the Meeting

   Agenda Item 1:
   The Meeting unanimously by way of amicable discussion resolved :

   For point a on the Agenda Item 1 of the Meeting :
   1. To accept the Company’s Annual Report for the book year 2023.
   2. To approve the Company’s Financial Statements for the book year 2023,
      which has been audited by the Public Accounting Firm “Imelda & Rekan”, wherein
      Ms. Anna Karina Wijaya as Partner has been appointed as the Company's
      Independent Public Accountant, as evident in his Report Number
      00117/2.1265/AU.1/03/1766-1/1/III/2024, March 28, 2024, with the opinion “Fairly
      Unmodified”.
   3. To accept the Board of Directors’ Report and to approve the Board of
      Commissioners’ Supervisory Duties Report for the book year 2023.
   4. To give full discharge to the members of the Company’s Board of Directors for their
      management duties and to the members of the Company’s Board of Commissioners
      for their supervisory duties, performed during the book year 2023, as long as such
      duties are stated in the Company’s Annual Report and Financial Statements for the
      book year 2023, except for fraud, embezzlement and other criminal acts.

For point b on the Agenda Item 1 of the Meeting :
   -To approve not to distribute dividend to the Company’s shareholders, as the
   Company suffer losses for the book year 2023.


Agenda Item 2:
The Meeting unanimously by way of amicable discussion resolved :

To authorize the Company's Board of Commissioners :
 1. Based on the recommendation of the Company’s Audit Committee, to appoint an
    Independent Public Accountant to audit the Consolidated Statements Of Financial
    Position, Consolidated Statements Of Profit Or Loss And Other Comprehensive
    Income and other parts of the Company's Financial Statements for the book year
    ended on December 31, 2024; and
 2. To determine the honorarium for the Independent Public Accountant and other
    requirements with respect to its appointment.


Agenda Item 3:
The Meeting unanimously by way of amicable discussion resolved :

For point a on the Agenda Item 3 of the Meeting :
1. To appoint the Company's members of the Board of Directors and the Board of
     Commissioners whose names were recommended by the Meeting of the
     Company’s Board of Commissioners, with the term of office effective as of the
     closing of the Meeting until the closing of the Company's Annual General Meeting
     of Shareholders held in the year 2026, with the following composition :

       Board of Directors :
       President Director               :   Mr. Husni Ali
       Vice President Director          :   Mr. Dr. Syahrul Effendi, SH, MM.
       Director                         :   Mrs. Marisa Kolonas
       Director                         :   Mr. Ir. Njudarsono Yusetijo
       Director                         :   Mr. Agus Gozali
       Director                         :   Mr. Hartono
       Director                         :   Mr. Chandraja Harita

       Board of Commissioners :
       President Commissioner           :   Mr. Dr. Ferry Siswojo Djongianto, SH, LLM
       Independent Vice
       President Commissioner           :   Mr. Drs. H. Lutfi Dahlan
       Commissioner                     :   Mr. Sriyanto
       Independent Commissioner         :   Mr. Ris Sutarto
       Independent Commissioner         :   Mr. Gatot Subroto
       Independent Commissioner         :   Mr. Drs. Syamsuddin Lologau

2.   To authorize the Company’s Board of Directors with the rights of substitution, to
     restate in the form of notarial deed on the decision which has been resolved in
     agenda item 3 point (a) of the Meeting and furthermore to apply any notifications
     to the Ministry of Justice and Human Rights of the Republic of Indonesia and to
     register in the company registration and for that purpose to do and perform any
     and all matters and actions as may be necessary or appropriate by the prevailing
     laws and regulations.

For point b on the Agenda Item 3 of the Meeting :
1. To authorize the Company's Board of Director through the Board of Directors
     Meeting on behalf of the Company's General Meeting of Shareholders to
     determine the rules regarding distribution of duties and powers of each member of
     the Company's Board of Directors.
2. To approve :
     a. to authorize the Company's Board of Commissioners to determine the amount
        of salary and other allowances for the Company's members of the Board of
        Directors.
     b. to determine the honorarium and other allowances for the Company's members
        of the Board of Commissioners which are adjusted as a whole to a maximum of
        10% (ten percent) above the total honorarium and other allowances received
        by each member of the Board of Commissioners of the Company for the
        previous financial year.
     c. to authorize the Company's Board of Commissioners to determine the
        distribution of the honorarium and other allowances to each Company's
        members of the Board of Commissioners.


                               Jakarta, June 26, 2024
                          The Company's Board of Directors